We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.8B
AUM Growth
+$485M
Cap. Flow
-$250M
Cap. Flow %
-2.12%
Top 10 Hldgs %
39.85%
Holding
1,230
New
34
Increased
603
Reduced
253
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 73.1%
2 Technology 4.03%
3 Financials 3.16%
4 Industrials 2.98%
5 Healthcare 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETQ
1076
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4K ﹤0.01%
136
RUBY
1077
DELISTED
Rubius Therapeutics, Inc
RUBY
$4K ﹤0.01%
503
AKBA icon
1078
Akebia Therapeutics
AKBA
$327M
$3K ﹤0.01%
740
AUPH icon
1079
Aurinia Pharmaceuticals
AUPH
$1.97B
$3K ﹤0.01%
577
EOLS icon
1080
Evolus
EOLS
$394M
$3K ﹤0.01%
173
PBYI icon
1081
Puma Biotechnology
PBYI
$406M
$3K ﹤0.01%
243
PGEN icon
1082
PUT
Precigen
PGEN
$1.93B
$3K ﹤0.01%
1,500
REPL icon
1083
Replimune Group
REPL
$814M
$3K ﹤0.01%
201
SIGA icon
1084
SIGA Technologies
SIGA
$223M
$3K ﹤0.01%
511
SLDB icon
1085
Solid Biosciences
SLDB
$771M
$3K ﹤0.01%
20
TVTX icon
1086
Travere Therapeutics
TVTX
$5.33B
$3K ﹤0.01%
263
URGN icon
1087
UroGen Pharma
URGN
$2B
$3K ﹤0.01%
133
-17
-11% -$556
TECX
1088
Tectonic Therapeutic
TECX
$573M
$3K ﹤0.01%
17
+4
+31% +$906
SYRS
1089
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3K ﹤0.01%
27
+5
+23% +$472
AMRS
1090
DELISTED
Amyris Inc.
AMRS
$3K ﹤0.01%
645
+146
+29% +$545
FLXN
1091
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3K ﹤0.01%
243
+36
+17% +$427
TBIO
1092
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3K ﹤0.01%
287
PGNX
1093
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
533
AKRX
1094
DELISTED
Akorn Inc
AKRX
$3K ﹤0.01%
792
ACHN
1095
DELISTED
Achillion Pharmaceuticals
ACHN
$3K ﹤0.01%
890
+128
+17% +$493
ACET icon
1096
Adicet Bio
ACET
$72.8M
$2K ﹤0.01%
2
ACIU icon
1097
AC Immune
ACIU
$227M
$2K ﹤0.01%
425
ADVM
1098
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
41
AUTL
1099
Autolus Therapeutics
AUTL
$386M
$2K ﹤0.01%
168
+53
+46% +$700
BCRX icon
1100
BioCryst Pharmaceuticals
BCRX
$2.37B
$2K ﹤0.01%
697

Similar funds

Daiwa Securities Group's Q3 2019 Portfolio in Review

As of Q3 2019, Daiwa Securities Group held 1,230 positions worth $11.8B, up 4.3% from $11.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Daiwa Securities Group's Q3 2019 filing shows 34 new, 603 increased, 253 reduced and 43 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M. The largest sale was Public Storage, an estimated $190M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 72% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M.
  • Daiwa Securities Group added most to Realty Income in Q3 2019, an estimated $211M increase.
  • Daiwa Securities Group's biggest Q3 2019 reduction was Public Storage, cutting an estimated $190M.
  • Daiwa Securities Group fully exited Coupa Software Incorporated in Q3 2019, selling an estimated $4.17M.
  • Daiwa Securities Group's ten largest holdings make up 40% of its $11.8B portfolio in Q3 2019.
  • Daiwa Securities Group opened 34 new positions and closed 43 in Q3 2019.
  • Daiwa Securities Group's portfolio value rose 4.3% quarter-over-quarter to $11.8B.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.